...
首页> 外文期刊>Canadian Journal of Physiology and Pharmacology >Activation of AMP-activated protein kinase (AMPK) inhibits protein synthesis: a potential strategy to prevent the development of cardiac hypertrophy.
【24h】

Activation of AMP-activated protein kinase (AMPK) inhibits protein synthesis: a potential strategy to prevent the development of cardiac hypertrophy.

机译:AMP激活的蛋白激酶(AMPK)的激活抑制了蛋白的合成:这是预防心脏肥大的潜在策略。

获取原文
获取原文并翻译 | 示例
           

摘要

A necessary mediator of cardiac myocyte enlargement is protein synthesis, which is controlled, in part, by the highly energy-consuming process of peptide-chain elongation. Recently, AMP-activated protein kinase (AMPK), which is a key regulator of cellular energy homeostasis, has been shown to phosphorylate a number of enzymes involved in the control of protein synthesis. Since AMPK may inhibit protein synthesis via a number of different pathways, it is possible that AMPK is also a key regulator of cardiac hypertrophy. Recent advances linking AMPK and the energy status of the cell to the regulation of protein synthesis and (or) cardiac myocyte hypertrophy will be discussed.
机译:心肌细胞扩张的必要介体是蛋白质合成,蛋白质合成部分地受到高度耗能的肽链延长过程的控制。最近,已显示出AMP激活的蛋白激酶(AMPK)是细胞能量稳态的关键调节剂,它可以磷酸化许多参与蛋白质合成控制的酶。由于AMPK可能通过许多不同的途径抑制蛋白质的合成,因此AMPK可能也是心脏肥大的关键调节剂。将讨论将AMPK和细胞能量状态与蛋白质合成和(或)心肌细胞肥大的调节联系起来的最新进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号